Improving testing capacity for animal diseases and food safety.
Purchase of a Real-Time Polymerase Chain Reaction System to Maintain and Expand VetLIRN Capacity
['FUNDING_OTHER'] · UNIVERSITY OF PENNSYLVANIA · NIH-11066640
This study is all about helping veterinarians test animals and food for harmful germs faster and more accurately, so they can keep both pets and people safe from illnesses like Salmonella and COVID-19.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-11066640 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the ability of veterinary laboratories to quickly and accurately test for harmful pathogens in animals and food products. By acquiring a state-of-the-art real-time polymerase chain reaction (PCR) system, the project aims to bolster the diagnostic capabilities of the Ryan Small Animal Hospital Clinical Microbiology Laboratory at the University of Pennsylvania. This will enable the laboratory to respond more effectively to public health threats posed by pathogens like Salmonella and SARS-CoV-2, ensuring better monitoring and surveillance of animal health and food safety.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include veterinarians, animal health professionals, and public health officials involved in monitoring animal diseases and food safety.
Not a fit: Patients who may not receive benefit from this research include those not involved in veterinary medicine or food safety, such as individuals seeking treatment for unrelated health conditions.
Why it matters
Potential benefit: If successful, this research could lead to improved public health outcomes by ensuring faster detection of dangerous pathogens in animals and food products.
How similar studies have performed: Other research has demonstrated success in enhancing laboratory testing capabilities for pathogen detection, indicating that this approach is both relevant and necessary.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: COLE, STEPHEN DOUGLAS — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: COLE, STEPHEN DOUGLAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.